CA
NZ
UK
AU
IND
US
Johnson & Johnson (NYSE:JNJ) shares are trading higher in Wednesday's session, outperforming a softer broader market, as two brokerages raised their price targets ahead of the company's third-quarter report scheduled for October 13. One raised its target to $290 and another to $303, with …
Eli Lilly (NYSE:LLY) shares are trading sharply higher in Wednesday's session after the FDA expanded approval for Jaypirca to cover first-line treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma, broadening the drug's addressable patient population. The news prompted a brokerage to raise its …
Nautilus Biotechnology (NASDAQ:NAUT), a Seattle-based, development-stage life sciences company building the Nautilus Voyager platform, is climbing sharply in Wednesday's session, with buying interest picking up as investors revisit a peer-reviewed publication in Nature Methods that validated the company's core technology. The study marked the …
Prime Medicine (NASDAQ:PRME), a Cambridge, Massachusetts-based, pre-commercial biotechnology company pioneering one-time genetic therapies through its Prime Editing platform, is extending its advance in Wednesday's session, building on a rally sparked a day earlier when the company dosed its first patient in a global Phase …
Recursion Pharmaceuticals (NASDAQ:RXRX) shares are trading lower in Wednesday's session, giving back a portion of the gains from a roughly 13% rally earlier this month that had been driven by renewed enthusiasm around the company's artificial intelligence partnerships. Today's pullback comes alongside a broader …
Savara (NASDAQ:SVRA), a clinical-stage biopharmaceutical company, is trading higher in Wednesday's session on above-average volume as investors respond to renewed bullish coverage ahead of a November 22 FDA decision on its lead candidate. One research firm initiated coverage with a bullish rating, while another …
China SXT Pharmaceuticals (NASDAQ:SXTC), a specialty pharmaceutical company incorporated in 2005 and headquartered in Taizhou, Jiangsu Province, China, that focuses on Traditional Chinese Medicine Pieces, is trading sharply higher in Wednesday's session, climbing 280.00% on volume far exceeding its usual turnover. No press release, …
VERAXA Biotech AG (NASDAQ:VRXA), a Zurich-based oncology company developing antibody-based cancer therapies, is trading sharply higher in Wednesday's session after detailing how it is implementing FDA-aligned New Approach Methodologies across its preclinical research programs. The company said the approach could accelerate clinical advancement of …
Zenas BioPharma (NASDAQ:ZBIO) shares are trading higher in Wednesday's session, with investor attention building around a scheduled virtual research and development event on October 27 covering the company's lead autoimmune disease programs. Recent bullish commentary has also highlighted the company's regulatory progress, contributing to …
Published market data showed Jaguar Health (NASDAQ:JAGX) gaining 18.8% to USD 5.62 on October 6, 2026. We searched the company's recent releases and filings and found no announcement dated October 5 or 6, so the cause of the day's move is unverified. The shares …
Please wait processing your request...